Home/ Supplements/ Vitamin K/ Vita-Lea Gold Multi+ With Vitamin K

Vita-Lea Gold Multi+ With Vitamin K

product on market Tablet or Pill Shaklee Safety: 99/100
99/100

This product looks safe

  • Folate: 668mg is 668.0× the Tolerable Upper Intake Level (1.0mg)
  • 64% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains vitamins A, C, D3, and E, which are supported by strong evidence for maintaining immune function and antioxidant defense. These nutrients play essential roles in cellular health and bone maintenance. The overall evidence coverage for this specific profile is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Folate: 668mg is 668.0× the Tolerable Upper Intake Level (1.0mg)

Label

Product Label

Label for Vita-Lea Gold Multi+ With Vitamin K
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Tablet(s)
Serving Size
60
Servings
Other Combinations
Product Type
64%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Total Carbohydrates
1 Gram(s) (1% DV)
Vitamin A
1500 mcg (167% DV)
Vitamin C
120 mg (133% DV)
25 mcg (125% DV)
1.7× RDA — within safe limits 608 studies (A:16, B:251)
40 mg (267% DV)
2.7× RDA — within safe limits 179 studies (A:3, B:90)
120 mcg (100% DV)
Within RDA (1.0× RDA) 275 studies (A:9, B:175)
2.25 mg (188% DV)
1.9× RDA — within safe limits 76 studies (A:0, B:33)
2.55 mg (196% DV)
2.0× RDA — within safe limits 13 studies (A:0, B:1)
30 mg (188% DV)
2.1× RDA — within safe limits 196 studies (A:5, B:63)
4 mg (235% DV)
3.1× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
668 mcg DFE (167% DV)
Exceeds UL by 668.0× (UL: 1.0 mg) 226 studies (A:10, B:105)
24 mcg (1000% DV)
10.0× RDA — above typical dose 139 studies (A:1, B:44)
300 mcg (1000% DV)
10.0× RDA — above typical dose 27 studies (A:0, B:11)
15 mg (300% DV)
3.0× RDA — within safe limits 2 studies — no high-quality reviews
Calcium
450 mg (35% DV)
350 mg (28% DV)
Within RDA (0.5× RDA) 13 studies (A:0, B:3)
150 mcg (100% DV)
Within RDA (1.0× RDA) 245 studies (A:4, B:133)
225 mg (54% DV)
Within RDA (0.5× RDA) 316 studies (A:8, B:159)
22.5 mg (205% DV)
2.0× RDA — within safe limits 263 studies (A:6, B:134)
70 mcg (127% DV)
1.3× RDA — within safe limits 173 studies (A:0, B:67)
1 mg (111% DV)
1.1× RDA — within safe limits 37 studies (A:0, B:11)
2.3 mg (100% DV)
Within RDA (1.0× RDA) 9 studies — no high-quality reviews
120 mcg (343% DV)
3.4× RDA — above typical dose 199 studies (A:1, B:55)
75 mcg (167% DV)
1.7× RDA — within safe limits 3 studies — no high-quality reviews
Sodium
5 mg (1% DV)
Market median: 600.0mg (7 products) 39 studies (A:2, B:13)
Nickel
5 mcg
Tin
10 mcg
20 mcg
Market median: 0.5mg (6 products) 1 studies (A:0, B:1)
1 mg
Market median: 3.0mg (58 products) 3 studies — no high-quality reviews
2 mg
Market median: 108.0mg (8 products) 9 studies (A:0, B:4)

Other Ingredients

Microcrystalline Cellulose Hydroxypropyl Methylcellulose Croscarmellose Sodium Spirulina Medium Chain Triglyceride Inositol Choline Bitartrate Alfalfa, Powder Grapefruit Flavonoids Hesperidin Complex Lemon Bioflavonoid Orange Bioflavonoid Rice Bran, Powder Rose Hips, Powder Acerola Extract Riboflavin
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take 2 tablets daily.

Warnings & Precautions

Caution: If taking blood-thinning medications, consult your physician prior to use.

Seal under cap for your protection.

Manufactured in a facility that may also process peanuts, tree nuts, milk, egg, soy, wheat, shellfish, and fish.

Formulation Notes

Backed by 7 clinical studies Supports optimal health with essential minerals, 100% + DV of all vitamins, plus extra B for energy and key nutrients to protect against free radicals. Features our patented Bioactivated Absorption System.

Gluten free No artificial flavors, sweeteners, or preservatives

The perfect multi for heart, brain, eye & bone health and guaranteed vitality

Additional Information

Shaklee Since 1956 Safe Proven 100% Guaranteed

Dr Shaklee

Product questions: 925-734-3638

Metadata

Product Details

DSLD Entry Date2023-12-14
Product TypeOther Combinations
FormTablet or Pill
BrandShaklee
DSLD ID301174
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.